NYSE:PLX | Cash Flow Statement | Protalix BioTherapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$3.78M
2026-03-31$18.32M$22.03M$761,000.00$4.22M$150,000.00
2025-12-31-$5.5M$2.03M$403,000.00-$1.11M$146,000.00
2025-09-30$2.36M
2025-06-30$164,000.00
2025-03-31-$3.62M-$5.06M$306,000.00-$312,000.00$5.08M
2024-12-31$6.49M$3.99M$425,000.00-$15.32M$3.63M
2024-09-30$3.24M
2024-06-30-$2.2M
2024-03-31-$4.6M$4.19M$598,000.00-$606,000.00
2023-12-31-$6.04M$3.6M$250,000.00-$342,000.00$0.00
2023-09-30-$1.85M
2023-06-30$19.34M
2023-03-31-$3.13M-$3M$248,000.00$4.73M$14.23M
2022-12-31-$3.74M-$2.61M$213,000.00$4.95M$4.08M
2022-09-30-$3.57M
2022-06-30-$5.33M
2022-03-31-$2.29M-$5.83M$229,000.00-$16.26M
2021-12-31-$6.67M-$5.09M$448,000.00$37.44M-$4.05M
2021-09-30-$4.2M
2021-06-30-$11.24M
2021-03-31-$5.48M-$9.83M$386,000.00-$30.68M$42.11M
2020-12-31$397,000.00-$7.55M$275,000.00$7.59M$4.65M
2020-09-30-$4.44M
2020-06-30-$4.15M
2020-03-31$1.67M-$7.12M$66,000.00-$35.08M$38.61M
2019-12-31$291,000.00-$3.69M$28,000.00$29,000.00
2019-09-30-$3.56M
2019-06-30-$7.74M
2019-03-31-$7.26M-$7.28M$170,000.00-$371,000.00
2018-12-31-$5.43M-$4M$188,000.00$84,000.00$0.00
2018-09-30-$5.32M
2018-06-30-$8.46M
2018-03-31-$7.24M-$9.41M$249,000.00-$328,000.00
2017-12-31-$13.31M$17.59M$290,000.00-$34,000.00$0.00
2017-09-30-$11.44M
2017-06-30$450,000.00
2017-03-31-$59.15M-$8.43M$220,000.00-$283,000.00-$6.73M
2016-12-31-$2.62M-$7.34M$117,000.00-$242,000.00$19.7M
2016-09-30-$7.29M
2016-06-30-$10.85M
2016-03-31-$8.6M-$9.63M$251,000.00-$293,000.00
2015-12-31$72.9M-$3.86M$4,000.00$39.9M
2015-09-30-$3.82M
2015-06-30-$5.07M
2015-03-31-$5.97M-$6.42M$99,000.00-$99,000.00
2014-12-31-$8.47M-$4.87M$168,000.00
2014-09-30-$8.01M
2014-06-30-$6.12M
2014-03-31-$7.35M-$8.34M$263,000.00
2013-12-31-$10.89M-$4.74M$222,000.00-$271,000.00
2013-09-30-$5.75M
2013-06-30-$6.84M
2013-03-31-$4.32M-$9.59M$642,000.00-$689,000.00
2012-12-31-$9.88M$1.82M$251,000.00-$376,000.00$134,000.00
2012-09-30-$5.48M
2012-06-30$9.64M
2012-03-31-$5.9M-$6.28M$810,000.00-$852,000.00$25.57M
2011-12-31-$8.91M-$6.61M$704,000.00-$747,000.00$14,000.00
2011-09-30-$8.88M
2011-06-30-$13.69M
2011-03-31-$5.05M-$3.99M$2.6M-$2.65M$20.94M
2010-12-31-$8.53M-$8.03M$1.04M-$1.08M$342,000.00
2010-09-30-$2.47M
2010-06-30-$10.04M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$6.6M-$11.99M$1.64M-$2.37M$9.33M
2024-12-31$2.93M$8.67M$1.28M$4.22M-$16.79M
2023-12-31$8.31M-$1.32M$1.15M-$16.71M$24.67M
2022-12-31-$14.93M-$25M$628,000.00-$5.04M$8.24M
2021-12-31-$27.58M-$10.29M$1.46M$18.92M$12.08M
2020-12-31-$6.52M-$26.11M$655,000.00-$19.95M$46.47M
2019-12-31-$18.28M-$19.36M$627,000.00-$883,000.00$0.00
2018-12-31-$26.46M-$7.74M$686,000.00-$591,000.00-$4.75M
2017-12-31-$83.44M-$9.99M$971,000.00-$1.12M-$1.42M
2016-12-31-$29.37M-$32.1M$849,000.00-$967,000.00$19.7M
2015-12-31$58.04M-$24.28M$464,000.00$39.39M$6.64M
2014-12-31-$29.94M-$29.28M$785,000.00-$1M
2013-12-31-$27.79M-$30.65M$1.89M-$2.1M
2012-12-31-$11.62M$635,000.00$2.07M-$2.29M$26.56M
2011-12-31-$36.53M-$23.57M$5.71M-$5.87M$20.93M
2010-12-31-$29M-$38.46M$7.86M-$7.99M$501,000.00
2009-12-31-$31.44M$44.45M$6.2M-$6.17M$293,000.00